IOL Chemicals and Pharmaceuticals Ltd receives approval CDE of NMPA, China for Ibuprofen

IOL Chemicals and Pharmaceuticals Limited's product, "Ibuprofen," has received approval from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA), China.

This approval authorizes the Company to export Ibuprofen to the Chinese markets. Ibuprofen is a widely used non-steroidal anti-inflammatory drug (NSAID) effective in relieving pain, reducing inflammation, and lowering fever.

Source : Equity Bulls

Keywords

IOLChemicalsandPharmaceuticals CDE NMPA China Approval Ibuprofen